ResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

ResMed (NYSE: RMD) announced that CEO Mick Farrell will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 1:30 p.m. EST via webcast. This conference offers an opportunity for investors to hear about ResMed’s innovative solutions for chronic diseases and its digital health technologies. Access to the live webcast and the replay will be available through their investor relations website. The presentation aims to highlight how ResMed is improving healthcare quality and reducing costs globally.

Positive

• Mick Farrell will present at a significant industry event, potentially increasing investor interest.
• Showcases ResMed's commitment to leading in digital health technologies and chronic disease management.

Negative

• None.

SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40^th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at approximately 1:30 p.m. (Eastern Standard Time) via webcast.

More information about this event, including access to the live, audio-only webcast, may be accessed by visiting https://investor.resmed.com. Conference attendees will be able to access the video webcast via the J.P. Morgan Digital Conference Book. The audio-only webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 9, 2022.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors	For media
Amy Wakeham	Jayme Rubenstein
+1 858.836.5000	+1 858.836.6798
investorrelations@resmed.com	news@resmed.com

FAQ

When will Mick Farrell present at the J.P. Morgan Healthcare Conference?

Mick Farrell will present on January 10, 2022, at 1:30 p.m. EST.

How can I access the webcast of the ResMed presentation?

The webcast can be accessed through ResMed's investor relations website.

What is the significance of the J.P. Morgan Healthcare Conference for ResMed?

It provides a platform for ResMed to share its innovations and business direction with investors.

What key focuses will ResMed highlight during the conference?

ResMed will emphasize its digital health technologies and solutions for chronic diseases.